BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 10804603)

  • 1. [Autologous transplantation of peripheral blood stem cells in the framework of treatment for hematologic neoplasms. II. Determination of CD34+ cells and progenitor colonies].
    Medinger P; Schneider P; Nicoloso de Faveri G; Zwicky C; Tissot JD
    Schweiz Med Wochenschr; 2000 Apr; 130(14):510-5. PubMed ID: 10804603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of CD34+ cells mobilized into the peripheral blood predicts the yield of the leukapheresis product and can replace progenitor assays.
    D'Hondt L; André M; Guillaume T; Feyens AM; Humblet Y; Doyen C; Bosly A; Dromelet A; Chatelain B; Symann M
    Cytokines Cell Mol Ther; 1997 Mar; 3(1):21-6. PubMed ID: 9287240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Large-volume leukapheresis in pediatric patients: pre-apheresis peripheral blood CD34+ cell count predicts progenitor cell yield.
    Díaz MA; Garcia-Sanchez F; Lillo R; Vicent MG; Vicario JL; Madero L
    Haematologica; 1999 Jan; 84(1):32-5. PubMed ID: 10091391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The importance of CD34+/CD33- cells in platelet engraftment after intensive therapy for cancer patients given peripheral blood stem cell rescue.
    Millar BC; Millar JL; Shepherd V; Blackwell P; Porter H; Cunningham D; Judson I; Treleaven J; Powles RL; Catovsky D
    Bone Marrow Transplant; 1998 Sep; 22(5):469-75. PubMed ID: 9733270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [CD34+ cell dose and hematologic recovery in allogeneic peripheral blood stem cell transplantation].
    Sawada H; Wake A; Yamasaki Y; Izumi Y
    Rinsho Ketsueki; 2000 Jun; 41(6):500-6. PubMed ID: 10921350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of engraftment after autologous peripheral blood progenitor cell transplantation: CD34, colony-forming unit-granulocyte-macrophage, or both?
    Jansen EM; Hanks SG; Terry C; Akard LP; Thompson JM; Dugan MJ; Jansen J
    Transfusion; 2007 May; 47(5):817-23. PubMed ID: 17465946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subsets of CD34+ hematopoietic progenitors and platelet recovery after high dose chemotherapy and peripheral blood stem cell transplantation.
    Meldgaard Knudsen L; Jensen L; Jarlbaek L; Hansen PG; Hansen SW; Drivsholm L; Nikolaisen K; Gaarsdal E; Johnsen HE
    Haematologica; 1999 Jun; 84(6):517-24. PubMed ID: 10366795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The number of CD34(+) cells in peripheral blood as a predictor of the CD34(+) yield in patients going to autologous stem cell transplantation.
    Basquiera AL; Abichain P; Damonte JC; Ricchi B; Sturich AG; Palazzo ED; García JJ
    J Clin Apher; 2006 Jul; 21(2):92-5. PubMed ID: 16106446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Large-scale expansion and transplantation of CD34(+) hematopoietic cells: in vitro and in vivo confirmation of neutropenia abrogation related to the expansion process without impairment of the long-term engraftment capacity.
    Boiron JM; Dazey B; Cailliot C; Launay B; Attal M; Mazurier F; McNiece IK; Ivanovic Z; Caraux J; Marit G; Reiffers J
    Transfusion; 2006 Nov; 46(11):1934-42. PubMed ID: 17076849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enumeration of CD34+ hematopoietic progenitor cells for clinical transplantation: comparison of three different methods.
    Venditti A; Battaglia A; Del Poeta G; Buccisano F; Maurillo L; Tamburini A; Del Moro B; Epiceno AM; Martiradonna M; Caravita T; Santinelli S; Adorno G; Picardi A; Zinno F; Lanti A; Bruno A; Suppo G; Franchi A; Franconi G; Amadori S
    Bone Marrow Transplant; 1999 Nov; 24(9):1019-27. PubMed ID: 10556963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation of purified autologous peripheral blood CD34+ cells with low T cell content using CliniMACS device--a local experience.
    Leong CF; Habsah A; Teh HS; Goh KY; Fadilah SA; Cheong SK
    Malays J Pathol; 2008 Jun; 30(1):31-6. PubMed ID: 19108409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etoposide 1.0 g/m2 or 1.5 g/m2 combined with granulocyte colony-stimulating factor for mobilization of peripheral blood stem cells in patients with malignancy: efficacy and toxicity.
    Li B; Yang JL; Shi YK; He XH; Han XH; Zhou SY; Liu P; Yang S; Zhang CG
    Cytotherapy; 2009; 11(3):362-71. PubMed ID: 19037766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical impact of a new automated system employed for peripheral blood stem cell collection.
    Del Fante C; Perotti C; Viarengo G; Bellotti L; Parisi C; Marchesi A; Tinelli C; Salvaneschi L
    J Clin Apher; 2006 Dec; 21(4):227-32. PubMed ID: 16847939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Autologous peripheral blood stem cells mobilization with etoposide plus rhG-CSF versus cyclophosphamide plus rhG-CSF].
    Shi YK; He XH; Han XH; Liu P; Yang JL; Zhou SY; Zhou AP; Zhang CG; Ai B
    Ai Zheng; 2003 Dec; 22(12):1311-6. PubMed ID: 14693058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can the stem cell mobilization technique influence CD34+ cell collection efficiency of leukapheresis procedures in patients with hematologic malignancies?
    Gidron A; Verma A; Doyle M; Boggio L; Evens A; Gordon L; Singhal S; Tallman M; Williams S; Winter J; Mehta J
    Bone Marrow Transplant; 2005 Feb; 35(3):243-6. PubMed ID: 15580281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring of CD34+ cells during leukapheresis allows a single, successful collection of hemopoietic progenitors in patients with low numbers of circulating stem cells.
    de Fabritiis P; Gonzalez M; Meloni G; De Propris MS; Bellucci R; Cordone I; Gozzer M; Leone G; Mandelli F
    Bone Marrow Transplant; 1999 Jun; 23(12):1229-36. PubMed ID: 10414908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mobilization, harvesting and selection of peripheral blood stem cells in patients with autoimmune diseases undergoing autologous hematopoietic stem cell transplantation.
    Statkute L; Verda L; Oyama Y; Traynor A; Villa M; Shook T; Clifton R; Jovanovic B; Satkus J; Loh Y; Quigley K; Yaung K; Gonda E; Krosnjar N; Spahovic D; Burt RK
    Bone Marrow Transplant; 2007 Mar; 39(6):317-29. PubMed ID: 17277794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD34 counts to predict the adequate collection of peripheral blood progenitor cells.
    Armitage S; Hargreaves R; Samson D; Brennan M; Kanfer E; Navarrete C
    Bone Marrow Transplant; 1997 Oct; 20(7):587-91. PubMed ID: 9337061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mobilization of autologous peripheral blood stem cells by combined chemotherapy and rhG-CSF].
    Shi H; Gu X; Zhu L
    Zhonghua Zhong Liu Za Zhi; 2001 Mar; 23(2):159-61. PubMed ID: 11783025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PBPC collection techniques: standard versus large volume leukapheresis (LVL) in donors and in patients.
    Gasová Z; Marinov I; Vodvárková S; Böhmová M; Bhuyian-Ludvíková Z
    Transfus Apher Sci; 2005 Apr; 32(2):167-76. PubMed ID: 15784451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.